Page 1517, Section 16.1, para 1, lines 1-3 which previously read:
Page 1517, Section 16.1, para 1, lines 1-3 which previously read:
The pharmacokinetics of CRP was tested in small shortterm studies in both healthy volunteers and in subjects with schizophrenia, with similar results [242] .
Should read:
The pharmacokinetics of CRP was tested in small short-term studies in healthy volunteers [235] and also in subjects with schizophrenia [242] , with similar results.
Page 1517, Section 16.1, para 1, lines 4-6 which previously read:
Cariprazine is rapidly absorbed, reaching peak concentrations between 3 and 4 h after oral dosing in healthy subjects.
Should read:
Cariprazine reached peak plasma concentrations between 3 and 4 h after oral dosing in healthy subjects.
Page 1517, Section 16.1, para 2, lines 1-5 which previously read:
Its pharmacokinetics were linear in terms of AUC but maximum concentrations were more than proportional within the dose range from 3 to 5 mg in healthy subjects. Mean halflife was 2-5 days (1.5-12.5 mg/day) in the subjects with schizophrenia [242].
Its pharmacokinetics were linear in terms of AUC but maximum concentrations were more than proportional within the single dose range from 0.5 to 2.5 mg in healthy subjects. Mean half-life was 2-5 days (1.5-12.5 mg/day) in the subjects with schizophrenia [235] . 
